Prevention and therapy of small cell lung cancer with brain metastasis

Abstract

Gao Chao, Yu Yonghua. Prevention and therapy of small cell lung cancer with brain metastasis[J]. Journal of International Oncology, 2014, 41(8): 588-592.

［1］ Blanchard P, Le Péchoux C. Prophylactic cranial irradiation in lung cancer［J］. Curr Opin Oncol, 2010, 22(2): 94-101. ［2］ Pesce GA, Klingbiel D, Ribi K, et al. Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase Ⅱ trial of the Sweiss Groupfor Clinical Cancer Research (SAKK 70/03)[J]. Eur J Cancer, 2012, 48(3): 377-384. ［3］ Patel S, Macdonald OK, Suntharalingam M. Evaluation of the use of prophylactic cranial irradiation in small cell lung cancer［J］. Cancer, 2009, 115(4): 842-850. ［4］胡晓, 陈明. 局限期小细胞肺癌预防性全脑照射：争议与研究进展［J］.中国肺癌杂志, 2013, 16(7): 373-377. ［5］ Tai P, Assouline A, Joseph K, et al. Prophylactic cranial irradiation for patients with limitedstage smallcell lung cancer with response to chemoradiation［J］. Clin Lung Cancer, 2013, 14(1): 40-44. ［6］ Schild SE, Foster NR, Meyers JP, et al. Prophylactic cranial irradiation in smallcell lung cancer: findings from a North Central Cancer Treatment Group Pooled Analysis［J］. Ann Oncol, 2012, 23(11): 2919-2924. ［7］ Giuliani M, Sun A, Bezjak A, et al. Utilization of prophylactic cranial irradiation in patients with limited stage small cell lung carcinoma［J］. Cancer, 2010, 116(24): 5694-5699. ［8］ Ramlov A, Tietze A, Khalil AA, et al. Prophylactic cranial irradiation in patients with small cell lung cancer. A retrospective study of recurrence, survival and morbidity［J］. Lung Cancer, 2012, 77(3): 561-566. ［9］ Paumier A, Cuenca X, Le Péchoux C. Prophylactic cranial irradiation in lung cancer［J］. Cancer Treat Rev, 2011, 37(4): 261-265. ［10］ Le Péchoux C, Dunant A, Senan S, et al. Standarddose versus higherdose prophylactic cranial irradiation (PCI) in patients with limitedstage smallcell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 9901, EORTC 2200308004, RTOG 0212, and IFCT 9901): a randomised clinical trial［J］. Lancet Oncol, 2009, 10(5): 467-474. ［11］ Slotman B, FaivreFinn C, Kramer G, et al. Prophylactic cranial irradiation in extensive smallcell lung cancer［J］. N Engl J Med, 2007, 357(7): 664-672. ［12］ Ganti AK, West WW, Zhen W. Current concepts in the management of small cell lung cancer［J］. Indian J Med Res, 2013, 137(6): 1043-1051. ［13］ Slotman BJ, Mauer ME, Bottomley A, et al. Prophylactic cranial irradiation in extensive smallcell lung cancer: shortterm healthrelated quality of life and patient reported symptoms: results of an international phase Ⅲ randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups. ［J］. J Clin Oncol, 2009, 27(1): 78-84. ［14］ HarfordWright E, Lewis KM, Vink R. Towards drug discovery for brain tumours: interaction of kinins and tumours at the blood brain barrier interface［J］. Recent Pat CNS Drug Discov, 2011, 6(1): 31-40. ［15］ Thompson EM, Frenkel EP, Neuwelt EA. The paradoxical effect of bevacizumab in the therapy of malignant gliomas［J］. Neurology, 2011, 76(1): 87-93. ［16］郭振勇, 赵伟杰, 刘菲. 炎症和高渗溶液对莫西沙星透过血脑脊液屏障影响的研究及疗效评价［J］. 中国医院用药评价与分析, 2010, 10(9): 822-823. ［17］任成波, 赵丽霞, 赵增虎, 等. 甘露醇在预防小细胞肺癌脑转移中的作用［J］. 现代肿瘤医学, 2012, 20(4): 744-745. ［18］钱皓瑜, 陈卓昌, 郭晓斌, 等. 尼莫司汀预防小细胞肺癌脑转移疗效观察［J］. 中华实用诊断与治疗杂志, 2011, 25(7): 701-702. ［19］ Liu LB, Xue YX, Liu YH. Bradykinin increases the permeability of the bloodtumor barrier by the caveolaemediated transcellular pathway［J］. J Neurooncol, 2010, 99(2): 187-194. ［20］ Qin LJ, Gu YT, Zhang H, et al. Bradykinininduced bloodtumor barrier opening is mediated by tumor necrosis factoralpha［J］. Neurosci Lett, 2009, 450(2): 172-175. ［21］ Ma T, Xue Y. RhoAmediated potential regulation of bloodtumor barrier permeability by bradykinin［J］. J Mol Neurosci, 2010, 42(1): 67-73. ［22］ Li Z, Liu YH, Xue YX, et al. Signal mechanisms underlying lowdose endothelial monocyteactivating polypeptideⅡinduced opening of the bloodtumor barrier［J］. J Mol Neurosci, 2012, 48(1): 291-301. ［23］ Gu YT, Xue YX, Wang YF, et al. Minoxidil sulfate induced the increase in bloodbrain tumor barrier permeability through ROS/RhoA/PI3K/PKB signaling pathway［J］. Neuropharmacology, 2013, 75: 407-415.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei.Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma： a real-world clinical study[J]. Journal of International Oncology, 2024, 51(6): 326-331.
[3]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[4]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[5]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[6]	Qian Xiaotao, Shi Ziyi, Hu Ge.A real-world clinical study of immunocheckpoint inhibitor maintenance therapy after radical radiotherapy and chemotherapy in stage Ⅲ-ⅣA esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2024, 51(3): 151-156.
[7]	Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing.Progress of radiotherapy in oligometastatic non-small cell lung cancer[J]. Journal of International Oncology, 2024, 51(3): 170-174.
[8]	Yue Hongyun, Zhang Baihong.Differentiation therapies in human cancers[J]. Journal of International Oncology, 2024, 51(2): 109-113.
[9]	Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan.Research progress on the histopathological growth patterns of colorectal liver metastasis[J]. Journal of International Oncology, 2024, 51(2): 114-118.
[10]	Jin Xudong, Chen Zhongjian, Mao Weimin.Research progress on the role of MTAP in malignant mesothelioma[J]. Journal of International Oncology, 2024, 51(2): 99-104.
[11]	He Jiahui, Hu Qinyong.Comparative analysis of lung cancer incidence and mortality trends and risk factors in China and the United States based on GBD data[J]. Journal of International Oncology, 2024, 51(1): 29-36.
[12]	Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei.Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients[J]. Journal of International Oncology, 2024, 51(1): 37-42.
[13]	Cui Tenglu, Lyu lu, Sun Pengfei.Application of radiotherapy combined with immunotherapy in the treatment of head and neck squamous cell carcinoma[J]. Journal of International Oncology, 2023, 50(9): 548-552.
[14]	Zhang Lu, Jiang Hua, Lin Zhou, Ma Chenying, Xu Xiaoting, Wang Lili, Zhou Juying.Analysis of curative effect and prognosis of immune checkpoint inhibitor in the treatment of recurrent and metastatic cervical cancer[J]. Journal of International Oncology, 2023, 50(8): 475-483.
[15]	Li Chenxi, Zhao Hongwei.Prognosis and influencing factors of platinum sensitive recurrent ovarian cancer treated by secondary cytoreduction surgery in patients with unsatisfactory primary cytoreduction surgery[J]. Journal of International Oncology, 2023, 50(6): 342-347.

Prevention and therapy of small cell lung cancer with brain metastasis

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments